nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—ACHE—Irinotecan—lung cancer	0.142	0.248	CbGbCtD
Donepezil—CYP2C9—Gefitinib—lung cancer	0.0419	0.0731	CbGbCtD
Donepezil—CYP2C9—Teniposide—lung cancer	0.0406	0.0709	CbGbCtD
Donepezil—CYP2D6—Gefitinib—lung cancer	0.0383	0.0669	CbGbCtD
Donepezil—CYP2D6—Vinorelbine—lung cancer	0.0295	0.0515	CbGbCtD
Donepezil—CYP3A4—Topotecan—lung cancer	0.0266	0.0465	CbGbCtD
Donepezil—CYP3A4—Gefitinib—lung cancer	0.0243	0.0425	CbGbCtD
Donepezil—CYP3A4—Teniposide—lung cancer	0.0236	0.0412	CbGbCtD
Donepezil—CYP2C9—Paclitaxel—lung cancer	0.0227	0.0396	CbGbCtD
Donepezil—CYP2D6—Erlotinib—lung cancer	0.0226	0.0395	CbGbCtD
Donepezil—CYP3A4—Vinorelbine—lung cancer	0.0187	0.0328	CbGbCtD
Donepezil—CYP2C9—Cisplatin—lung cancer	0.0182	0.0318	CbGbCtD
Donepezil—CYP2D6—Vinblastine—lung cancer	0.0182	0.0317	CbGbCtD
Donepezil—CYP3A4—Crizotinib—lung cancer	0.0149	0.0261	CbGbCtD
Donepezil—CYP3A4—Erlotinib—lung cancer	0.0144	0.0251	CbGbCtD
Donepezil—CYP3A4—Paclitaxel—lung cancer	0.0132	0.023	CbGbCtD
Donepezil—CYP3A4—Irinotecan—lung cancer	0.013	0.0227	CbGbCtD
Donepezil—HTR2A—phrenic nerve—lung cancer	0.0119	0.43	CbGeAlD
Donepezil—CYP3A4—Vinblastine—lung cancer	0.0116	0.0202	CbGbCtD
Donepezil—CYP2D6—Doxorubicin—lung cancer	0.0112	0.0195	CbGbCtD
Donepezil—CYP3A4—Etoposide—lung cancer	0.0104	0.0182	CbGbCtD
Donepezil—CYP3A4—Docetaxel—lung cancer	0.00952	0.0166	CbGbCtD
Donepezil—CYP3A4—Doxorubicin—lung cancer	0.0071	0.0124	CbGbCtD
Donepezil—HTR2A—pulmonary artery—lung cancer	0.00431	0.156	CbGeAlD
Donepezil—SIGMAR1—mammary gland—lung cancer	0.00204	0.0739	CbGeAlD
Donepezil—CYP2C9—mammary gland—lung cancer	0.00132	0.0478	CbGeAlD
Donepezil—SIGMAR1—bronchus—lung cancer	0.00112	0.0406	CbGeAlD
Donepezil—SIGMAR1—trachea—lung cancer	0.00101	0.0364	CbGeAlD
Donepezil—SIGMAR1—cardiac atrium—lung cancer	0.000945	0.0342	CbGeAlD
Donepezil—SIGMAR1—bone marrow—lung cancer	0.000798	0.0289	CbGeAlD
Donepezil—ACHE—lymph node—lung cancer	0.000737	0.0267	CbGeAlD
Donepezil—HTR2A—respiratory system—lung cancer	0.000725	0.0263	CbGeAlD
Donepezil—SIGMAR1—lung—lung cancer	0.000723	0.0262	CbGeAlD
Donepezil—HTR2A—epithelium—lung cancer	0.000606	0.0219	CbGeAlD
Donepezil—HTR2A—trachea—lung cancer	0.000536	0.0194	CbGeAlD
Donepezil—SIGMAR1—lymph node—lung cancer	0.000494	0.0179	CbGeAlD
Donepezil—HTR2A—lung—lung cancer	0.000385	0.0139	CbGeAlD
Donepezil—Arthralgia—Docetaxel—lung cancer	9.59e-05	0.000311	CcSEcCtD
Donepezil—Myalgia—Docetaxel—lung cancer	9.59e-05	0.000311	CcSEcCtD
Donepezil—Nausea—Vinorelbine—lung cancer	9.58e-05	0.000311	CcSEcCtD
Donepezil—Gastrointestinal disorder—Etoposide—lung cancer	9.56e-05	0.00031	CcSEcCtD
Donepezil—Dyspepsia—Paclitaxel—lung cancer	9.55e-05	0.00031	CcSEcCtD
Donepezil—Body temperature increased—Cisplatin—lung cancer	9.55e-05	0.00031	CcSEcCtD
Donepezil—Asthenia—Irinotecan—lung cancer	9.55e-05	0.00031	CcSEcCtD
Donepezil—Fatigue—Etoposide—lung cancer	9.54e-05	0.00031	CcSEcCtD
Donepezil—Constipation—Etoposide—lung cancer	9.46e-05	0.000307	CcSEcCtD
Donepezil—Pain—Etoposide—lung cancer	9.46e-05	0.000307	CcSEcCtD
Donepezil—Dysuria—Doxorubicin—lung cancer	9.44e-05	0.000306	CcSEcCtD
Donepezil—Decreased appetite—Paclitaxel—lung cancer	9.43e-05	0.000306	CcSEcCtD
Donepezil—Dry mouth—Docetaxel—lung cancer	9.38e-05	0.000305	CcSEcCtD
Donepezil—Haemoglobin—Methotrexate—lung cancer	9.38e-05	0.000304	CcSEcCtD
Donepezil—Gastrointestinal disorder—Paclitaxel—lung cancer	9.37e-05	0.000304	CcSEcCtD
Donepezil—Fatigue—Paclitaxel—lung cancer	9.36e-05	0.000304	CcSEcCtD
Donepezil—Haemorrhage—Methotrexate—lung cancer	9.33e-05	0.000303	CcSEcCtD
Donepezil—Hepatitis—Methotrexate—lung cancer	9.33e-05	0.000303	CcSEcCtD
Donepezil—Pollakiuria—Doxorubicin—lung cancer	9.33e-05	0.000303	CcSEcCtD
Donepezil—Asthenia—Gemcitabine—lung cancer	9.3e-05	0.000302	CcSEcCtD
Donepezil—Constipation—Paclitaxel—lung cancer	9.28e-05	0.000301	CcSEcCtD
Donepezil—Pain—Paclitaxel—lung cancer	9.28e-05	0.000301	CcSEcCtD
Donepezil—Confusional state—Docetaxel—lung cancer	9.27e-05	0.000301	CcSEcCtD
Donepezil—Pharyngitis—Methotrexate—lung cancer	9.26e-05	0.000301	CcSEcCtD
Donepezil—Urinary tract disorder—Methotrexate—lung cancer	9.21e-05	0.000299	CcSEcCtD
Donepezil—Oedema—Docetaxel—lung cancer	9.2e-05	0.000299	CcSEcCtD
Donepezil—Weight increased—Doxorubicin—lung cancer	9.19e-05	0.000298	CcSEcCtD
Donepezil—Pruritus—Gemcitabine—lung cancer	9.17e-05	0.000298	CcSEcCtD
Donepezil—Urethral disorder—Methotrexate—lung cancer	9.15e-05	0.000297	CcSEcCtD
Donepezil—Infection—Docetaxel—lung cancer	9.14e-05	0.000297	CcSEcCtD
Donepezil—Weight decreased—Doxorubicin—lung cancer	9.13e-05	0.000296	CcSEcCtD
Donepezil—Feeling abnormal—Etoposide—lung cancer	9.12e-05	0.000296	CcSEcCtD
Donepezil—Hyperglycaemia—Doxorubicin—lung cancer	9.11e-05	0.000296	CcSEcCtD
Donepezil—Diarrhoea—Irinotecan—lung cancer	9.1e-05	0.000295	CcSEcCtD
Donepezil—Pneumonia—Doxorubicin—lung cancer	9.05e-05	0.000294	CcSEcCtD
Donepezil—Gastrointestinal pain—Etoposide—lung cancer	9.05e-05	0.000294	CcSEcCtD
Donepezil—Shock—Docetaxel—lung cancer	9.05e-05	0.000294	CcSEcCtD
Donepezil—Nervous system disorder—Docetaxel—lung cancer	9.02e-05	0.000293	CcSEcCtD
Donepezil—Thrombocytopenia—Docetaxel—lung cancer	9.01e-05	0.000292	CcSEcCtD
Donepezil—Infestation—Doxorubicin—lung cancer	9e-05	0.000292	CcSEcCtD
Donepezil—Infestation NOS—Doxorubicin—lung cancer	9e-05	0.000292	CcSEcCtD
Donepezil—Visual impairment—Methotrexate—lung cancer	8.99e-05	0.000292	CcSEcCtD
Donepezil—Feeling abnormal—Paclitaxel—lung cancer	8.94e-05	0.00029	CcSEcCtD
Donepezil—Hypersensitivity—Cisplatin—lung cancer	8.9e-05	0.000289	CcSEcCtD
Donepezil—Gastrointestinal pain—Paclitaxel—lung cancer	8.87e-05	0.000288	CcSEcCtD
Donepezil—Diarrhoea—Gemcitabine—lung cancer	8.87e-05	0.000288	CcSEcCtD
Donepezil—Renal failure—Doxorubicin—lung cancer	8.85e-05	0.000287	CcSEcCtD
Donepezil—Dizziness—Irinotecan—lung cancer	8.8e-05	0.000286	CcSEcCtD
Donepezil—Urticaria—Etoposide—lung cancer	8.79e-05	0.000285	CcSEcCtD
Donepezil—Jaundice—Doxorubicin—lung cancer	8.77e-05	0.000285	CcSEcCtD
Donepezil—Anorexia—Docetaxel—lung cancer	8.77e-05	0.000285	CcSEcCtD
Donepezil—Body temperature increased—Etoposide—lung cancer	8.75e-05	0.000284	CcSEcCtD
Donepezil—Abdominal pain—Etoposide—lung cancer	8.75e-05	0.000284	CcSEcCtD
Donepezil—Urinary tract infection—Doxorubicin—lung cancer	8.75e-05	0.000284	CcSEcCtD
Donepezil—Conjunctivitis—Doxorubicin—lung cancer	8.75e-05	0.000284	CcSEcCtD
Donepezil—Tinnitus—Methotrexate—lung cancer	8.7e-05	0.000282	CcSEcCtD
Donepezil—Asthenia—Cisplatin—lung cancer	8.67e-05	0.000281	CcSEcCtD
Donepezil—Sweating—Doxorubicin—lung cancer	8.63e-05	0.00028	CcSEcCtD
Donepezil—Urticaria—Paclitaxel—lung cancer	8.62e-05	0.00028	CcSEcCtD
Donepezil—Hypotension—Docetaxel—lung cancer	8.59e-05	0.000279	CcSEcCtD
Donepezil—Haematuria—Doxorubicin—lung cancer	8.58e-05	0.000279	CcSEcCtD
Donepezil—Abdominal pain—Paclitaxel—lung cancer	8.58e-05	0.000278	CcSEcCtD
Donepezil—Body temperature increased—Paclitaxel—lung cancer	8.58e-05	0.000278	CcSEcCtD
Donepezil—Epistaxis—Doxorubicin—lung cancer	8.49e-05	0.000276	CcSEcCtD
Donepezil—Vomiting—Irinotecan—lung cancer	8.46e-05	0.000275	CcSEcCtD
Donepezil—Rash—Irinotecan—lung cancer	8.39e-05	0.000272	CcSEcCtD
Donepezil—Dermatitis—Irinotecan—lung cancer	8.38e-05	0.000272	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Docetaxel—lung cancer	8.38e-05	0.000272	CcSEcCtD
Donepezil—Chills—Methotrexate—lung cancer	8.37e-05	0.000272	CcSEcCtD
Donepezil—Headache—Irinotecan—lung cancer	8.34e-05	0.000271	CcSEcCtD
Donepezil—Insomnia—Docetaxel—lung cancer	8.32e-05	0.00027	CcSEcCtD
Donepezil—Diarrhoea—Cisplatin—lung cancer	8.27e-05	0.000268	CcSEcCtD
Donepezil—Paraesthesia—Docetaxel—lung cancer	8.26e-05	0.000268	CcSEcCtD
Donepezil—Alopecia—Methotrexate—lung cancer	8.25e-05	0.000268	CcSEcCtD
Donepezil—Vomiting—Gemcitabine—lung cancer	8.24e-05	0.000267	CcSEcCtD
Donepezil—Bradycardia—Doxorubicin—lung cancer	8.23e-05	0.000267	CcSEcCtD
Donepezil—Dyspnoea—Docetaxel—lung cancer	8.2e-05	0.000266	CcSEcCtD
Donepezil—Somnolence—Docetaxel—lung cancer	8.18e-05	0.000265	CcSEcCtD
Donepezil—Mental disorder—Methotrexate—lung cancer	8.17e-05	0.000265	CcSEcCtD
Donepezil—Rash—Gemcitabine—lung cancer	8.17e-05	0.000265	CcSEcCtD
Donepezil—Dermatitis—Gemcitabine—lung cancer	8.16e-05	0.000265	CcSEcCtD
Donepezil—Hypersensitivity—Etoposide—lung cancer	8.15e-05	0.000265	CcSEcCtD
Donepezil—Erythema—Methotrexate—lung cancer	8.12e-05	0.000264	CcSEcCtD
Donepezil—Malnutrition—Methotrexate—lung cancer	8.12e-05	0.000264	CcSEcCtD
Donepezil—Haemoglobin—Doxorubicin—lung cancer	8.12e-05	0.000264	CcSEcCtD
Donepezil—Headache—Gemcitabine—lung cancer	8.12e-05	0.000264	CcSEcCtD
Donepezil—Rhinitis—Doxorubicin—lung cancer	8.1e-05	0.000263	CcSEcCtD
Donepezil—Dyspepsia—Docetaxel—lung cancer	8.1e-05	0.000263	CcSEcCtD
Donepezil—Haemorrhage—Doxorubicin—lung cancer	8.08e-05	0.000262	CcSEcCtD
Donepezil—Hepatitis—Doxorubicin—lung cancer	8.08e-05	0.000262	CcSEcCtD
Donepezil—Hypoaesthesia—Doxorubicin—lung cancer	8.04e-05	0.000261	CcSEcCtD
Donepezil—Pharyngitis—Doxorubicin—lung cancer	8.02e-05	0.00026	CcSEcCtD
Donepezil—Decreased appetite—Docetaxel—lung cancer	8e-05	0.00026	CcSEcCtD
Donepezil—Hypersensitivity—Paclitaxel—lung cancer	8e-05	0.000259	CcSEcCtD
Donepezil—Urinary tract disorder—Doxorubicin—lung cancer	7.98e-05	0.000259	CcSEcCtD
Donepezil—Oedema peripheral—Doxorubicin—lung cancer	7.96e-05	0.000258	CcSEcCtD
Donepezil—Dysgeusia—Methotrexate—lung cancer	7.95e-05	0.000258	CcSEcCtD
Donepezil—Gastrointestinal disorder—Docetaxel—lung cancer	7.94e-05	0.000258	CcSEcCtD
Donepezil—Asthenia—Etoposide—lung cancer	7.94e-05	0.000258	CcSEcCtD
Donepezil—Fatigue—Docetaxel—lung cancer	7.93e-05	0.000257	CcSEcCtD
Donepezil—Urethral disorder—Doxorubicin—lung cancer	7.92e-05	0.000257	CcSEcCtD
Donepezil—Nausea—Irinotecan—lung cancer	7.9e-05	0.000257	CcSEcCtD
Donepezil—Pain—Docetaxel—lung cancer	7.87e-05	0.000255	CcSEcCtD
Donepezil—Constipation—Docetaxel—lung cancer	7.87e-05	0.000255	CcSEcCtD
Donepezil—Back pain—Methotrexate—lung cancer	7.86e-05	0.000255	CcSEcCtD
Donepezil—Pruritus—Etoposide—lung cancer	7.83e-05	0.000254	CcSEcCtD
Donepezil—Visual impairment—Doxorubicin—lung cancer	7.79e-05	0.000253	CcSEcCtD
Donepezil—Asthenia—Paclitaxel—lung cancer	7.79e-05	0.000253	CcSEcCtD
Donepezil—Nausea—Gemcitabine—lung cancer	7.7e-05	0.00025	CcSEcCtD
Donepezil—Vomiting—Cisplatin—lung cancer	7.68e-05	0.000249	CcSEcCtD
Donepezil—Pruritus—Paclitaxel—lung cancer	7.68e-05	0.000249	CcSEcCtD
Donepezil—Vision blurred—Methotrexate—lung cancer	7.66e-05	0.000248	CcSEcCtD
Donepezil—Rash—Cisplatin—lung cancer	7.62e-05	0.000247	CcSEcCtD
Donepezil—Dermatitis—Cisplatin—lung cancer	7.61e-05	0.000247	CcSEcCtD
Donepezil—Feeling abnormal—Docetaxel—lung cancer	7.58e-05	0.000246	CcSEcCtD
Donepezil—Diarrhoea—Etoposide—lung cancer	7.57e-05	0.000246	CcSEcCtD
Donepezil—Ill-defined disorder—Methotrexate—lung cancer	7.54e-05	0.000245	CcSEcCtD
Donepezil—Tinnitus—Doxorubicin—lung cancer	7.53e-05	0.000244	CcSEcCtD
Donepezil—Gastrointestinal pain—Docetaxel—lung cancer	7.52e-05	0.000244	CcSEcCtD
Donepezil—Anaemia—Methotrexate—lung cancer	7.51e-05	0.000244	CcSEcCtD
Donepezil—Diarrhoea—Paclitaxel—lung cancer	7.42e-05	0.000241	CcSEcCtD
Donepezil—Malaise—Methotrexate—lung cancer	7.33e-05	0.000238	CcSEcCtD
Donepezil—Dizziness—Etoposide—lung cancer	7.32e-05	0.000238	CcSEcCtD
Donepezil—Vertigo—Methotrexate—lung cancer	7.3e-05	0.000237	CcSEcCtD
Donepezil—Abdominal pain—Docetaxel—lung cancer	7.27e-05	0.000236	CcSEcCtD
Donepezil—Body temperature increased—Docetaxel—lung cancer	7.27e-05	0.000236	CcSEcCtD
Donepezil—Chills—Doxorubicin—lung cancer	7.25e-05	0.000235	CcSEcCtD
Donepezil—Arrhythmia—Doxorubicin—lung cancer	7.22e-05	0.000234	CcSEcCtD
Donepezil—Dizziness—Paclitaxel—lung cancer	7.18e-05	0.000233	CcSEcCtD
Donepezil—Nausea—Cisplatin—lung cancer	7.18e-05	0.000233	CcSEcCtD
Donepezil—Alopecia—Doxorubicin—lung cancer	7.14e-05	0.000232	CcSEcCtD
Donepezil—Cough—Methotrexate—lung cancer	7.09e-05	0.00023	CcSEcCtD
Donepezil—Mental disorder—Doxorubicin—lung cancer	7.08e-05	0.00023	CcSEcCtD
Donepezil—Convulsion—Methotrexate—lung cancer	7.04e-05	0.000228	CcSEcCtD
Donepezil—Vomiting—Etoposide—lung cancer	7.04e-05	0.000228	CcSEcCtD
Donepezil—Erythema—Doxorubicin—lung cancer	7.03e-05	0.000228	CcSEcCtD
Donepezil—Malnutrition—Doxorubicin—lung cancer	7.03e-05	0.000228	CcSEcCtD
Donepezil—Rash—Etoposide—lung cancer	6.98e-05	0.000226	CcSEcCtD
Donepezil—Dermatitis—Etoposide—lung cancer	6.97e-05	0.000226	CcSEcCtD
Donepezil—Headache—Etoposide—lung cancer	6.93e-05	0.000225	CcSEcCtD
Donepezil—Flatulence—Doxorubicin—lung cancer	6.93e-05	0.000225	CcSEcCtD
Donepezil—Chest pain—Methotrexate—lung cancer	6.92e-05	0.000224	CcSEcCtD
Donepezil—Arthralgia—Methotrexate—lung cancer	6.92e-05	0.000224	CcSEcCtD
Donepezil—Myalgia—Methotrexate—lung cancer	6.92e-05	0.000224	CcSEcCtD
Donepezil—Tension—Doxorubicin—lung cancer	6.9e-05	0.000224	CcSEcCtD
Donepezil—Vomiting—Paclitaxel—lung cancer	6.9e-05	0.000224	CcSEcCtD
Donepezil—Dysgeusia—Doxorubicin—lung cancer	6.89e-05	0.000224	CcSEcCtD
Donepezil—Rash—Paclitaxel—lung cancer	6.84e-05	0.000222	CcSEcCtD
Donepezil—Dermatitis—Paclitaxel—lung cancer	6.84e-05	0.000222	CcSEcCtD
Donepezil—Discomfort—Methotrexate—lung cancer	6.83e-05	0.000222	CcSEcCtD
Donepezil—Nervousness—Doxorubicin—lung cancer	6.83e-05	0.000222	CcSEcCtD
Donepezil—Back pain—Doxorubicin—lung cancer	6.8e-05	0.000221	CcSEcCtD
Donepezil—Headache—Paclitaxel—lung cancer	6.8e-05	0.000221	CcSEcCtD
Donepezil—Hypersensitivity—Docetaxel—lung cancer	6.78e-05	0.00022	CcSEcCtD
Donepezil—Muscle spasms—Doxorubicin—lung cancer	6.76e-05	0.000219	CcSEcCtD
Donepezil—Confusional state—Methotrexate—lung cancer	6.68e-05	0.000217	CcSEcCtD
Donepezil—Vision blurred—Doxorubicin—lung cancer	6.63e-05	0.000215	CcSEcCtD
Donepezil—Asthenia—Docetaxel—lung cancer	6.6e-05	0.000214	CcSEcCtD
Donepezil—Infection—Methotrexate—lung cancer	6.59e-05	0.000214	CcSEcCtD
Donepezil—Nausea—Etoposide—lung cancer	6.57e-05	0.000213	CcSEcCtD
Donepezil—Ill-defined disorder—Doxorubicin—lung cancer	6.53e-05	0.000212	CcSEcCtD
Donepezil—Pruritus—Docetaxel—lung cancer	6.51e-05	0.000211	CcSEcCtD
Donepezil—Nervous system disorder—Methotrexate—lung cancer	6.5e-05	0.000211	CcSEcCtD
Donepezil—Anaemia—Doxorubicin—lung cancer	6.5e-05	0.000211	CcSEcCtD
Donepezil—Thrombocytopenia—Methotrexate—lung cancer	6.49e-05	0.000211	CcSEcCtD
Donepezil—Agitation—Doxorubicin—lung cancer	6.46e-05	0.00021	CcSEcCtD
Donepezil—Nausea—Paclitaxel—lung cancer	6.45e-05	0.000209	CcSEcCtD
Donepezil—Hyperhidrosis—Methotrexate—lung cancer	6.41e-05	0.000208	CcSEcCtD
Donepezil—Malaise—Doxorubicin—lung cancer	6.34e-05	0.000206	CcSEcCtD
Donepezil—Vertigo—Doxorubicin—lung cancer	6.32e-05	0.000205	CcSEcCtD
Donepezil—Anorexia—Methotrexate—lung cancer	6.32e-05	0.000205	CcSEcCtD
Donepezil—Syncope—Doxorubicin—lung cancer	6.31e-05	0.000205	CcSEcCtD
Donepezil—Diarrhoea—Docetaxel—lung cancer	6.29e-05	0.000204	CcSEcCtD
Donepezil—Hypotension—Methotrexate—lung cancer	6.19e-05	0.000201	CcSEcCtD
Donepezil—Loss of consciousness—Doxorubicin—lung cancer	6.18e-05	0.000201	CcSEcCtD
Donepezil—Cough—Doxorubicin—lung cancer	6.14e-05	0.000199	CcSEcCtD
Donepezil—Convulsion—Doxorubicin—lung cancer	6.09e-05	0.000198	CcSEcCtD
Donepezil—Dizziness—Docetaxel—lung cancer	6.08e-05	0.000197	CcSEcCtD
Donepezil—Hypertension—Doxorubicin—lung cancer	6.07e-05	0.000197	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Methotrexate—lung cancer	6.04e-05	0.000196	CcSEcCtD
Donepezil—Insomnia—Methotrexate—lung cancer	6e-05	0.000195	CcSEcCtD
Donepezil—Chest pain—Doxorubicin—lung cancer	5.99e-05	0.000194	CcSEcCtD
Donepezil—Arthralgia—Doxorubicin—lung cancer	5.99e-05	0.000194	CcSEcCtD
Donepezil—Myalgia—Doxorubicin—lung cancer	5.99e-05	0.000194	CcSEcCtD
Donepezil—Anxiety—Doxorubicin—lung cancer	5.97e-05	0.000194	CcSEcCtD
Donepezil—Paraesthesia—Methotrexate—lung cancer	5.95e-05	0.000193	CcSEcCtD
Donepezil—Discomfort—Doxorubicin—lung cancer	5.92e-05	0.000192	CcSEcCtD
Donepezil—Dyspnoea—Methotrexate—lung cancer	5.91e-05	0.000192	CcSEcCtD
Donepezil—Somnolence—Methotrexate—lung cancer	5.89e-05	0.000191	CcSEcCtD
Donepezil—Dry mouth—Doxorubicin—lung cancer	5.86e-05	0.00019	CcSEcCtD
Donepezil—Vomiting—Docetaxel—lung cancer	5.85e-05	0.00019	CcSEcCtD
Donepezil—Dyspepsia—Methotrexate—lung cancer	5.84e-05	0.000189	CcSEcCtD
Donepezil—Rash—Docetaxel—lung cancer	5.8e-05	0.000188	CcSEcCtD
Donepezil—Dermatitis—Docetaxel—lung cancer	5.79e-05	0.000188	CcSEcCtD
Donepezil—Confusional state—Doxorubicin—lung cancer	5.79e-05	0.000188	CcSEcCtD
Donepezil—Decreased appetite—Methotrexate—lung cancer	5.76e-05	0.000187	CcSEcCtD
Donepezil—Headache—Docetaxel—lung cancer	5.76e-05	0.000187	CcSEcCtD
Donepezil—Oedema—Doxorubicin—lung cancer	5.74e-05	0.000186	CcSEcCtD
Donepezil—Gastrointestinal disorder—Methotrexate—lung cancer	5.72e-05	0.000186	CcSEcCtD
Donepezil—Fatigue—Methotrexate—lung cancer	5.72e-05	0.000185	CcSEcCtD
Donepezil—Infection—Doxorubicin—lung cancer	5.7e-05	0.000185	CcSEcCtD
Donepezil—Pain—Methotrexate—lung cancer	5.67e-05	0.000184	CcSEcCtD
Donepezil—Shock—Doxorubicin—lung cancer	5.65e-05	0.000183	CcSEcCtD
Donepezil—Nervous system disorder—Doxorubicin—lung cancer	5.63e-05	0.000183	CcSEcCtD
Donepezil—Thrombocytopenia—Doxorubicin—lung cancer	5.62e-05	0.000182	CcSEcCtD
Donepezil—Hyperhidrosis—Doxorubicin—lung cancer	5.55e-05	0.00018	CcSEcCtD
Donepezil—Anorexia—Doxorubicin—lung cancer	5.47e-05	0.000178	CcSEcCtD
Donepezil—Nausea—Docetaxel—lung cancer	5.46e-05	0.000177	CcSEcCtD
Donepezil—Feeling abnormal—Methotrexate—lung cancer	5.46e-05	0.000177	CcSEcCtD
Donepezil—Gastrointestinal pain—Methotrexate—lung cancer	5.42e-05	0.000176	CcSEcCtD
Donepezil—Hypotension—Doxorubicin—lung cancer	5.36e-05	0.000174	CcSEcCtD
Donepezil—Urticaria—Methotrexate—lung cancer	5.27e-05	0.000171	CcSEcCtD
Donepezil—Abdominal pain—Methotrexate—lung cancer	5.24e-05	0.00017	CcSEcCtD
Donepezil—Body temperature increased—Methotrexate—lung cancer	5.24e-05	0.00017	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.23e-05	0.00017	CcSEcCtD
Donepezil—Insomnia—Doxorubicin—lung cancer	5.19e-05	0.000169	CcSEcCtD
Donepezil—Paraesthesia—Doxorubicin—lung cancer	5.15e-05	0.000167	CcSEcCtD
Donepezil—Dyspnoea—Doxorubicin—lung cancer	5.12e-05	0.000166	CcSEcCtD
Donepezil—Somnolence—Doxorubicin—lung cancer	5.1e-05	0.000166	CcSEcCtD
Donepezil—Dyspepsia—Doxorubicin—lung cancer	5.05e-05	0.000164	CcSEcCtD
Donepezil—Decreased appetite—Doxorubicin—lung cancer	4.99e-05	0.000162	CcSEcCtD
Donepezil—Gastrointestinal disorder—Doxorubicin—lung cancer	4.96e-05	0.000161	CcSEcCtD
Donepezil—Fatigue—Doxorubicin—lung cancer	4.95e-05	0.000161	CcSEcCtD
Donepezil—Constipation—Doxorubicin—lung cancer	4.91e-05	0.000159	CcSEcCtD
Donepezil—Pain—Doxorubicin—lung cancer	4.91e-05	0.000159	CcSEcCtD
Donepezil—Hypersensitivity—Methotrexate—lung cancer	4.88e-05	0.000159	CcSEcCtD
Donepezil—Asthenia—Methotrexate—lung cancer	4.76e-05	0.000154	CcSEcCtD
Donepezil—Feeling abnormal—Doxorubicin—lung cancer	4.73e-05	0.000154	CcSEcCtD
Donepezil—Gastrointestinal pain—Doxorubicin—lung cancer	4.69e-05	0.000152	CcSEcCtD
Donepezil—Pruritus—Methotrexate—lung cancer	4.69e-05	0.000152	CcSEcCtD
Donepezil—Urticaria—Doxorubicin—lung cancer	4.56e-05	0.000148	CcSEcCtD
Donepezil—Abdominal pain—Doxorubicin—lung cancer	4.54e-05	0.000147	CcSEcCtD
Donepezil—Body temperature increased—Doxorubicin—lung cancer	4.54e-05	0.000147	CcSEcCtD
Donepezil—Diarrhoea—Methotrexate—lung cancer	4.54e-05	0.000147	CcSEcCtD
Donepezil—Dizziness—Methotrexate—lung cancer	4.38e-05	0.000142	CcSEcCtD
Donepezil—Hypersensitivity—Doxorubicin—lung cancer	4.23e-05	0.000137	CcSEcCtD
Donepezil—Vomiting—Methotrexate—lung cancer	4.22e-05	0.000137	CcSEcCtD
Donepezil—Rash—Methotrexate—lung cancer	4.18e-05	0.000136	CcSEcCtD
Donepezil—Dermatitis—Methotrexate—lung cancer	4.18e-05	0.000136	CcSEcCtD
Donepezil—Headache—Methotrexate—lung cancer	4.15e-05	0.000135	CcSEcCtD
Donepezil—Asthenia—Doxorubicin—lung cancer	4.12e-05	0.000134	CcSEcCtD
Donepezil—Pruritus—Doxorubicin—lung cancer	4.06e-05	0.000132	CcSEcCtD
Donepezil—Nausea—Methotrexate—lung cancer	3.94e-05	0.000128	CcSEcCtD
Donepezil—Diarrhoea—Doxorubicin—lung cancer	3.93e-05	0.000127	CcSEcCtD
Donepezil—Dizziness—Doxorubicin—lung cancer	3.8e-05	0.000123	CcSEcCtD
Donepezil—Vomiting—Doxorubicin—lung cancer	3.65e-05	0.000118	CcSEcCtD
Donepezil—Rash—Doxorubicin—lung cancer	3.62e-05	0.000117	CcSEcCtD
Donepezil—Dermatitis—Doxorubicin—lung cancer	3.62e-05	0.000117	CcSEcCtD
Donepezil—Headache—Doxorubicin—lung cancer	3.6e-05	0.000117	CcSEcCtD
Donepezil—Nausea—Doxorubicin—lung cancer	3.41e-05	0.000111	CcSEcCtD
Donepezil—CYP2D6—Metabolism—GSTA2—lung cancer	1.89e-05	0.000206	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.88e-05	0.000205	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MMP9—lung cancer	1.88e-05	0.000204	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTA2—lung cancer	1.88e-05	0.000204	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CDKN1A—lung cancer	1.87e-05	0.000204	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PTEN—lung cancer	1.87e-05	0.000203	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CKB—lung cancer	1.83e-05	0.000199	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTA1—lung cancer	1.83e-05	0.000199	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—AKT1—lung cancer	1.82e-05	0.000198	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ANXA1—lung cancer	1.82e-05	0.000197	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTA1—lung cancer	1.81e-05	0.000197	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCC3—lung cancer	1.81e-05	0.000196	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCC3—lung cancer	1.79e-05	0.000195	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EP300—lung cancer	1.78e-05	0.000194	CbGpPWpGaD
Donepezil—ACHE—Metabolism—APOA1—lung cancer	1.77e-05	0.000192	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FLT1—lung cancer	1.76e-05	0.000191	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AKR1C1—lung cancer	1.75e-05	0.00019	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CG—lung cancer	1.74e-05	0.000189	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AKR1C1—lung cancer	1.73e-05	0.000189	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—SRC—lung cancer	1.73e-05	0.000189	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTM2—lung cancer	1.72e-05	0.000187	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CNDP2—lung cancer	1.72e-05	0.000187	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOTCH3—lung cancer	1.72e-05	0.000187	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APP—lung cancer	1.72e-05	0.000187	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FGF9—lung cancer	1.71e-05	0.000186	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—UGT1A1—lung cancer	1.7e-05	0.000185	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.69e-05	0.000184	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—VEGFA—lung cancer	1.69e-05	0.000184	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—UGT1A1—lung cancer	1.68e-05	0.000183	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MTMR3—lung cancer	1.68e-05	0.000182	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—STAT3—lung cancer	1.67e-05	0.000182	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NRAS—lung cancer	1.67e-05	0.000181	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—POMC—lung cancer	1.66e-05	0.00018	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GNG11—lung cancer	1.64e-05	0.000178	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PGAM1—lung cancer	1.63e-05	0.000178	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JUNB—lung cancer	1.63e-05	0.000177	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GNG11—lung cancer	1.62e-05	0.000177	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.62e-05	0.000176	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CG—lung cancer	1.62e-05	0.000176	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MAPK3—lung cancer	1.6e-05	0.000174	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CG—lung cancer	1.58e-05	0.000172	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALDOA—lung cancer	1.56e-05	0.00017	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP2A7—lung cancer	1.56e-05	0.00017	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MYC—lung cancer	1.55e-05	0.000169	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALDOA—lung cancer	1.55e-05	0.000168	CbGpPWpGaD
Donepezil—ACHE—Metabolism—POMC—lung cancer	1.54e-05	0.000167	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CD—lung cancer	1.53e-05	0.000167	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SDC4—lung cancer	1.53e-05	0.000166	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EGFR—lung cancer	1.52e-05	0.000165	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NCOA3—lung cancer	1.51e-05	0.000165	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—POMC—lung cancer	1.51e-05	0.000164	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NCOA3—lung cancer	1.5e-05	0.000163	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CREBBP—lung cancer	1.5e-05	0.000163	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—STK11—lung cancer	1.48e-05	0.000161	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.48e-05	0.00016	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ADCY1—lung cancer	1.47e-05	0.00016	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCG2—lung cancer	1.47e-05	0.00016	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL6R—lung cancer	1.47e-05	0.00016	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCG2—lung cancer	1.46e-05	0.000159	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ADCY1—lung cancer	1.46e-05	0.000159	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ENO2—lung cancer	1.44e-05	0.000157	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HPGDS—lung cancer	1.44e-05	0.000157	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.44e-05	0.000156	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—KRAS—lung cancer	1.44e-05	0.000156	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HPGDS—lung cancer	1.43e-05	0.000156	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ENO2—lung cancer	1.43e-05	0.000156	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FOXO3—lung cancer	1.43e-05	0.000155	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.42e-05	0.000155	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CD—lung cancer	1.42e-05	0.000154	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.4e-05	0.000153	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ALB—lung cancer	1.4e-05	0.000152	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTT1—lung cancer	1.4e-05	0.000152	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—MAP2K1—lung cancer	1.4e-05	0.000152	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CD—lung cancer	1.39e-05	0.000151	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—RRM1—lung cancer	1.39e-05	0.000151	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTA3—lung cancer	1.39e-05	0.000151	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTT1—lung cancer	1.39e-05	0.000151	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GCLC—lung cancer	1.38e-05	0.000151	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP2A6—lung cancer	1.38e-05	0.000151	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP2A6—lung cancer	1.37e-05	0.000149	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GCLC—lung cancer	1.37e-05	0.000149	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.37e-05	0.000149	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AVP—lung cancer	1.34e-05	0.000146	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CB—lung cancer	1.34e-05	0.000145	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CA—lung cancer	1.32e-05	0.000143	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ENO1—lung cancer	1.31e-05	0.000143	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—B4GALT5—lung cancer	1.31e-05	0.000142	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ENO1—lung cancer	1.3e-05	0.000142	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.3e-05	0.000141	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IGF1R—lung cancer	1.29e-05	0.00014	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CXCL8—lung cancer	1.28e-05	0.00014	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.28e-05	0.000139	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TP53—lung cancer	1.28e-05	0.000139	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTA4—lung cancer	1.27e-05	0.000138	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HES1—lung cancer	1.27e-05	0.000138	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—RAF1—lung cancer	1.24e-05	0.000135	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTA2—lung cancer	1.24e-05	0.000135	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CB—lung cancer	1.24e-05	0.000135	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTGS2—lung cancer	1.23e-05	0.000133	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—IL2—lung cancer	1.23e-05	0.000133	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HRAS—lung cancer	1.22e-05	0.000133	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CB—lung cancer	1.21e-05	0.000132	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTA1—lung cancer	1.19e-05	0.00013	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCC3—lung cancer	1.18e-05	0.000128	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP2E1—lung cancer	1.18e-05	0.000128	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL6—lung cancer	1.17e-05	0.000127	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP2E1—lung cancer	1.17e-05	0.000127	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCL8—lung cancer	1.17e-05	0.000127	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NQO1—lung cancer	1.16e-05	0.000127	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ERBB3—lung cancer	1.16e-05	0.000126	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NQO1—lung cancer	1.15e-05	0.000126	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AKR1C1—lung cancer	1.14e-05	0.000124	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.13e-05	0.000123	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.12e-05	0.000122	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL2—lung cancer	1.11e-05	0.000121	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—UGT1A1—lung cancer	1.11e-05	0.000121	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TERT—lung cancer	1.11e-05	0.000121	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—AKT1—lung cancer	1.08e-05	0.000117	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FGFR1—lung cancer	1.08e-05	0.000117	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GNG11—lung cancer	1.07e-05	0.000116	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTEN—lung cancer	1.07e-05	0.000116	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HIF1A—lung cancer	1.06e-05	0.000115	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—STK11—lung cancer	1.05e-05	0.000114	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—STK11—lung cancer	1.04e-05	0.000113	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APOA1—lung cancer	1.02e-05	0.000111	CbGpPWpGaD
Donepezil—ACHE—Metabolism—EP300—lung cancer	1.02e-05	0.000111	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALDOA—lung cancer	1.02e-05	0.000111	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KDR—lung cancer	1.01e-05	0.00011	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NCOA3—lung cancer	9.9e-06	0.000108	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9.77e-06	0.000106	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTP1—lung cancer	9.71e-06	0.000106	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ADCY1—lung cancer	9.63e-06	0.000105	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCG2—lung cancer	9.63e-06	0.000105	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTP1—lung cancer	9.63e-06	0.000105	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CAT—lung cancer	9.45e-06	0.000103	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ENO2—lung cancer	9.44e-06	0.000103	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HPGDS—lung cancer	9.44e-06	0.000103	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPP2R1B—lung cancer	9.39e-06	0.000102	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CAT—lung cancer	9.37e-06	0.000102	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KIT—lung cancer	9.35e-06	0.000102	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CG—lung cancer	9.35e-06	0.000102	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APC—lung cancer	9.35e-06	0.000102	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—NRAS—lung cancer	9.35e-06	0.000102	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	9.31e-06	0.000101	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EGF—lung cancer	9.24e-06	0.0001	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCB1—lung cancer	9.19e-06	0.0001	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTT1—lung cancer	9.16e-06	9.96e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCB1—lung cancer	9.11e-06	9.91e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GCLC—lung cancer	9.05e-06	9.85e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP2A6—lung cancer	9.05e-06	9.85e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TYMS—lung cancer	9.03e-06	9.82e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—MAPK3—lung cancer	8.95e-06	9.73e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TYMS—lung cancer	8.95e-06	9.73e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTM1—lung cancer	8.92e-06	9.7e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—POMC—lung cancer	8.9e-06	9.67e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTM1—lung cancer	8.85e-06	9.62e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—BRAF—lung cancer	8.79e-06	9.55e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6R—lung cancer	8.68e-06	9.44e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CREBBP—lung cancer	8.67e-06	9.42e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ENO1—lung cancer	8.58e-06	9.33e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—EGFR—lung cancer	8.52e-06	9.26e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP1A1—lung cancer	8.46e-06	9.2e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ERCC2—lung cancer	8.39e-06	9.12e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP1A1—lung cancer	8.39e-06	9.12e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ERCC2—lung cancer	8.32e-06	9.04e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAP2K1—lung cancer	8.27e-06	8.99e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CD—lung cancer	8.22e-06	8.93e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CA—lung cancer	8.14e-06	8.85e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—KRAS—lung cancer	8.04e-06	8.75e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP2E1—lung cancer	7.7e-06	8.37e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NQO1—lung cancer	7.61e-06	8.28e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CA—lung cancer	7.55e-06	8.21e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CA—lung cancer	7.39e-06	8.04e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MDM2—lung cancer	7.36e-06	8e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RAF1—lung cancer	7.34e-06	7.98e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOA1—lung cancer	7.26e-06	7.89e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ERBB2—lung cancer	7.26e-06	7.89e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOA1—lung cancer	7.2e-06	7.82e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CB—lung cancer	7.16e-06	7.79e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MTOR—lung cancer	7.16e-06	7.79e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.89e-06	7.49e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCL8—lung cancer	6.88e-06	7.48e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—STK11—lung cancer	6.86e-06	7.46e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HRAS—lung cancer	6.84e-06	7.44e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AKT1—lung cancer	6.65e-06	7.23e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CG—lung cancer	6.63e-06	7.21e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CASP3—lung cancer	6.59e-06	7.16e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL2—lung cancer	6.58e-06	7.15e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CG—lung cancer	6.57e-06	7.14e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL6—lung cancer	6.54e-06	7.12e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCND1—lung cancer	6.41e-06	6.97e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JUN—lung cancer	6.4e-06	6.96e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTP1—lung cancer	6.35e-06	6.9e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—POMC—lung cancer	6.31e-06	6.86e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—POMC—lung cancer	6.25e-06	6.8e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP9—lung cancer	6.22e-06	6.77e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDKN1A—lung cancer	6.2e-06	6.74e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTEN—lung cancer	6.19e-06	6.73e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CAT—lung cancer	6.18e-06	6.72e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—AKT1—lung cancer	6.16e-06	6.7e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CREBBP—lung cancer	6.14e-06	6.68e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CREBBP—lung cancer	6.09e-06	6.62e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AKT1—lung cancer	6.04e-06	6.57e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCB1—lung cancer	6.01e-06	6.54e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TYMS—lung cancer	5.9e-06	6.42e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EP300—lung cancer	5.9e-06	6.42e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTM1—lung cancer	5.83e-06	6.34e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CD—lung cancer	5.83e-06	6.33e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CD—lung cancer	5.78e-06	6.28e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALB—lung cancer	5.75e-06	6.25e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SRC—lung cancer	5.74e-06	6.24e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALB—lung cancer	5.7e-06	6.2e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VEGFA—lung cancer	5.59e-06	6.08e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—STAT3—lung cancer	5.53e-06	6.02e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP1A1—lung cancer	5.53e-06	6.01e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NRAS—lung cancer	5.52e-06	6e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ERCC2—lung cancer	5.49e-06	5.97e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK3—lung cancer	5.29e-06	5.75e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MYC—lung cancer	5.14e-06	5.59e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CB—lung cancer	5.08e-06	5.52e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CB—lung cancer	5.03e-06	5.47e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS2—lung cancer	5.03e-06	5.47e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EGFR—lung cancer	5.03e-06	5.47e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS2—lung cancer	4.99e-06	5.42e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KRAS—lung cancer	4.75e-06	5.17e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOA1—lung cancer	4.75e-06	5.16e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTEN—lung cancer	4.39e-06	4.77e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CA—lung cancer	4.37e-06	4.75e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTEN—lung cancer	4.35e-06	4.73e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CG—lung cancer	4.33e-06	4.71e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TP53—lung cancer	4.22e-06	4.59e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—EP300—lung cancer	4.18e-06	4.55e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—EP300—lung cancer	4.15e-06	4.51e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—POMC—lung cancer	4.12e-06	4.48e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HRAS—lung cancer	4.04e-06	4.39e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CREBBP—lung cancer	4.02e-06	4.37e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6—lung cancer	3.87e-06	4.2e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CD—lung cancer	3.81e-06	4.14e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALB—lung cancer	3.76e-06	4.09e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKT1—lung cancer	3.57e-06	3.88e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CB—lung cancer	3.32e-06	3.61e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS2—lung cancer	3.29e-06	3.58e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CA—lung cancer	3.1e-06	3.37e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CA—lung cancer	3.07e-06	3.34e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTEN—lung cancer	2.87e-06	3.12e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—EP300—lung cancer	2.74e-06	2.97e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AKT1—lung cancer	2.53e-06	2.75e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AKT1—lung cancer	2.51e-06	2.73e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CA—lung cancer	2.02e-06	2.2e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AKT1—lung cancer	1.65e-06	1.8e-05	CbGpPWpGaD
